Opinion|Videos|January 30, 2025
FDA-Approved IV Iron Formulations
Panelists discuss how modern FDA-approved intravenous iron formulations, including ferric carboxymaltose, ferumoxytol, and iron sucrose, offer improved safety profiles and more efficient iron delivery compared with older compounds, thanks to their more stable carbohydrate shells and controlled iron release mechanisms.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Could you provide an overview of the FDA-approved IV iron formulations used in the treatment of IDA? Additionally, what are the structural differences between the older and newer IV iron formulations?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads
2
MID Models Reduce Adverse Events, Lower Costs in Oncology: Kenneth Komorny, PharmD, BCPS
3
TrumpRx Launch Brings Savings—and Uncertainty
4
Contributor: Reimagining Beneficiary Engagement in Accountable Care Models to Make America Healthy Again
5
